Palliative Care in Lung Cancer: A Review

Abstract

Lung cancer patients are at high risk of suffering due to severe and refractory symptoms, concomitant respiratory comorbidity, frequent disease progression, and treatment that can worsen and compromise quality of life. Palliative care (PC) has shown multiple benefits to cancer patients such as better quality of life, higher patient and family satisfaction, improved disease understanding, less symptom burden, fewer depressive symptoms, less aggressive end of life care, and even improved survival with early implementation. For these reasons, multiple societies have recognized PC as an essential component of lung cancer care, and early PC is recommended for patients with metastatic disease or refractory symptoms. Unfortunately, utilization of PC is both low and often near the end of life, increasing risk for suffering. Misconceptions about PC often underlie delayed referral to PC. This review summarizes the literature for utilization of PC in lung cancer and focuses on patient benefits, misconceptions, barriers, and implementation.

Keywords

lung cancer - palliative care - symptom control - end-of-life

• References

• 1 Morita T, Akechi T, Ikenaga M , et al. Late referrals to specialized palliative care service in Japan. J Clin Oncol 2005; 23 (12) 2637-2644
• 2 Ward AM, Agar M, Koczwara B. Collaborating or co-existing: a survey of attitudes of medical oncologists toward specialist palliative care. Palliat Med 2009; 23 (8) 698-707
• 3 Charalambous H, Pallis A, Hasan B, O'Brien M. Attitudes and referral patterns of lung cancer specialists in Europe to Specialized Palliative Care (SPC) and the practice of Early Palliative Care (EPC). BMC Palliat Care 2014; 13 (1) 59
• 4 Smith CB, Nelson JE, Berman AR , et al. Lung cancer physicians' referral practices for palliative care consultation. Ann Oncol 2012; 23 (2) 382-387
• 5 Ford DW, Koch KA, Ray DE , et al. Palliative and end-of-life care in lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143 (5 Suppl): e498S-e512S
• 6 Alt-Epping B, Stäritz AE, Simon ST , et al; Hospice And Palliative Care Evaluation Hope Working Group. What is special about patients with lung cancer and pulmonary metastases in palliative care? Results from a nationwide survey. J Palliat Med 2012; 15 (9) 971-977
• 7 Weingaertner V, Scheve C, Gerdes V , et al; PAALiativ Project; PAALiativ Project. Breathlessness, functional status, distress, and palliative care needs over time in patients with advanced chronic obstructive pulmonary disease or lung cancer: a cohort study. J Pain Symptom Manage 2014; 48 (4) 569-81.e1
• 8 Wysham NG, Cox CE, Wolf SP, Kamal AH. Symptom burden of chronic lung disease compared with lung cancer at time of referral for palliative care consultation. Ann Am Thorac Soc 2015; 12 (9) 1294-1301
• 9 Levy MH, Adolph MD, Back A , et al; NCCN (National Comprehensive Cancer Network). Palliative care. J Natl Compr Canc Netw 2012; 10 (10) 1284-1309
• 10 Temel JS, Greer JA, Muzikansky A , et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010; 363 (8) 733-742
• 11 Singer PA, Martin DK, Kelner M. Quality end-of-life care: patients' perspectives. JAMA 1999; 281 (2) 163-168
• 12 Steinhauser KE, Christakis NA, Clipp EC , et al. Preparing for the end of life: preferences of patients, families, physicians, and other care providers. J Pain Symptom Manage 2001; 22 (3) 727-737
• 13 Steinhauser KE, Clipp EC, McNeilly M, Christakis NA, McIntyre LM, Tulsky JA. In search of a good death: observations of patients, families, and providers. Ann Intern Med 2000; 132 (10) 825-832
• 14 Steinhauser KE, Christakis NA, Clipp EC, McNeilly M, McIntyre L, Tulsky JA. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA 2000; 284 (19) 2476-2482
• 15 Rose JH, O'Toole EE, Dawson NV , et al. Perspectives, preferences, care practices, and outcomes among older and middle-aged patients with late-stage cancer. J Clin Oncol 2004; 22 (24) 4907-4917
• 16 Voogt E, van der Heide A, Rietjens JA , et al. Attitudes of patients with incurable cancer toward medical treatment in the last phase of life. J Clin Oncol 2005; 23 (9) 2012-2019
• 17 Greer JA, Pirl WF, Jackson VA , et al. Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer. J Clin Oncol 2012; 30 (4) 394-400
• 18 Earle CC, Park ER, Lai B, Weeks JC, Ayanian JZ, Block S. Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol 2003; 21 (6) 1133-1138
• 19 Kapo JM, Akgün KM. Integrating palliative care into the care of patients with advanced lung cancer. Cancer J 2015; 21 (5) 434-439
• 20 Mosher CE, Ott MA, Hanna N, Jalal SI, Champion VL. Coping with physical and psychological symptoms: a qualitative study of advanced lung cancer patients and their family caregivers. Support Care Cancer 2015; 23 (7) 2053-2060
• 21 Molassiotis A, Uyterlinde W, Hollen PJ, Sarna L, Palmer P, Krishnasamy M. Supportive care in lung cancer: milestones over the past 40 years. J Thorac Oncol 2015; 10 (1) 10-18
• 22 Philip J, Hudson P, Bostanci A , et al. Metastatic non-small cell lung cancer: a benchmark for quality end-of-life cancer care?. Med J Aust 2015; 202 (3) 139-143
• 23 Vergnenègre A, Hominal S, Tchalla AE , et al; GFPC 0804 team Assessment of palliative care for advanced non-small-cell lung cancer in France: a prospective observational multicenter study (GFPC 0804 study). Lung Cancer 2013; 82 (2) 353-357
• 24 Lutz S, Norrell R, Bertucio C , et al. Symptom frequency and severity in patients with metastatic or locally recurrent lung cancer: a prospective study using the lung cancer symptom scale in a community hospital. J Palliat Med 2001; 4 (2) 157-165
• 25 Simone II CB, Vapiwala N, Hampshire MK, Metz JM. Palliative care in the management of lung cancer: analgesic utilization and barriers to optimal pain management. J Opioid Manag 2012; 8 (1) 9-16
• 26 Cooley ME. Symptoms in adults with lung cancer. A systematic research review. J Pain Symptom Manage 2000; 19 (2) 137-153
• 27 Koczywas M, Cristea M, Thomas J , et al. Interdisciplinary palliative care intervention in metastatic non-small-cell lung cancer. Clin Lung Cancer 2013; 14 (6) 736-744
• 28 Hopwood P, Stephens RJ ; The Medical Research Council (MRC) Lung Cancer Working Party. Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. Br J Cancer 1995; 71 (3) 633-636
• 29 Yennurajalingam S, Urbauer DL, Casper KL , et al. Impact of a palliative care consultation team on cancer-related symptoms in advanced cancer patients referred to an outpatient supportive care clinic. J Pain Symptom Manage 2011; 41 (1) 49-56
• 30 Hopwood P, Stephens RJ. Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol 2000; 18 (4) 893-903
• 31 Li J, Girgis A. Supportive care needs: are patients with lung cancer a neglected population?. Psychooncology 2006; 15 (6) 509-516
• 32 Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC. Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 2004; 22 (2) 315-321
• 33 Temel JS, McCannon J, Greer JA , et al. Aggressiveness of care in a prospective cohort of patients with advanced NSCLC. Cancer 2008; 113 (4) 826-833
• 34 Earle CC, Landrum MB, Souza JM, Neville BA, Weeks JC, Ayanian JZ. Aggressiveness of cancer care near the end of life: is it a quality-of-care issue?. J Clin Oncol 2008; 26 (23) 3860-3866
• 35 Iwashyna TJ, Christakis NA. Attitude and self-reported practice regarding hospice referral in a national sample of internists. J Palliat Med 1998; 1 (3) 241-248
• 36 Rickerson E, Harrold J, Kapo J, Carroll JT, Casarett D. Timing of hospice referral and families' perceptions of services: are earlier hospice referrals better?. J Am Geriatr Soc 2005; 53 (5) 819-823
• 37 Christakis NA, Escarce JJ. Survival of Medicare patients after enrollment in hospice programs. N Engl J Med 1996; 335 (3) 172-178
• 38 Osta BE, Palmer JL, Paraskevopoulos T , et al. Interval between first palliative care consult and death in patients diagnosed with advanced cancer at a comprehensive cancer center. J Palliat Med 2008; 11 (1) 51-57
• 39 Facts and Figures on Hospice Care. Nation Hospice Palliative Care Org 2014. Available from http://www.nhpco.org/hospice-statistics-research-press-room/facts-hospice-and-palliative-care . Accessed on February 8, 2016
• 40 Weeks JC, Catalano PJ, Cronin A , et al. Patients' expectations about effects of chemotherapy for advanced cancer. N Engl J Med 2012; 367 (17) 1616-1625
• 41 Mack JW, Walling A, Dy S , et al. Patient beliefs that chemotherapy may be curative and care received at the end of life among patients with metastatic lung and colorectal cancer. Cancer 2015; 121 (11) 1891-1897
• 42 Leighl NB, Shepherd FA, Zawisza D , et al. Enhancing treatment decision-making: pilot study of a treatment decision aid in stage IV non-small cell lung cancer. Br J Cancer 2008; 98 (11) 1769-1773
• 43 Temel JS, Greer JA, Admane S , et al. Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care. J Clin Oncol 2011; 29 (17) 2319-2326
• 44 Simoff MJ, Lally B, Slade MG , et al. Symptom management in patients with lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143 (5 Suppl): e455S-e497S
• 45 Smith TJ, Temin S, Alesi ER , et al. American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 2012; 30 (8) 880-887
• 46 Cherny NI, Catane R, Kosmidis P ; ESMO Taskforce on Supportive and Palliative Care. ESMO takes a stand on supportive and palliative care. Ann Oncol 2003; 14 (9) 1335-1337
• 47 Pantilat SZ, O'Riordan DL, Dibble SL, Landefeld CS. Hospital-based palliative medicine consultation: a randomized controlled trial. Arch Intern Med 2010; 170 (22) 2038-2040
• 48 Gade G, Venohr I, Conner D , et al. Impact of an inpatient palliative care team: a randomized control trial. J Palliat Med 2008; 11 (2) 180-190
• 49 Brumley R, Enguidanos S, Jamison P , et al. Increased satisfaction with care and lower costs: results of a randomized trial of in-home palliative care. J Am Geriatr Soc 2007; 55 (7) 993-1000
• 50 Follwell M, Burman D, Le LW , et al. Phase II study of an outpatient palliative care intervention in patients with metastatic cancer. J Clin Oncol 2009; 27 (2) 206-213
• 51 Strasser F, Sweeney C, Willey J, Benisch-Tolley S, Palmer JL, Bruera E. Impact of a half-day multidisciplinary symptom control and palliative care outpatient clinic in a comprehensive cancer center on recommendations, symptom intensity, and patient satisfaction: a retrospective descriptive study. J Pain Symptom Manage 2004; 27 (6) 481-491
• 52 Temel JS, Jackson VA, Billings JA , et al. Phase II study: integrated palliative care in newly diagnosed advanced non-small-cell lung cancer patients. J Clin Oncol 2007; 25 (17) 2377-2382
• 53 Meyers FJ, Linder J. Simultaneous care: disease treatment and palliative care throughout illness. J Clin Oncol 2003; 21 (7) 1412-1415
• 54 Meyers FJ, Linder J, Beckett L, Christensen S, Blais J, Gandara DR. Simultaneous care: a model approach to the perceived conflict between investigational therapy and palliative care. J Pain Symptom Manage 2004; 28 (6) 548-556
• 55 Muir JC, Daly F, Davis MS , et al. Integrating palliative care into the outpatient, private practice oncology setting. J Pain Symptom Manage 2010; 40 (1) 126-135
• 56 Le BH, Mileshkin L, Doan K , et al. Acceptability of early integration of palliative care in patients with incurable lung cancer. J Palliat Med 2014; 17 (5) 553-558
• 57 Wright AA, Zhang B, Ray A , et al. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 2008; 300 (14) 1665-1673
• 58 Malin JL. Bridging the divide: integrating cancer-directed therapy and palliative care. J Clin Oncol 2004; 22 (17) 3438-3440
• 59 Connor SR, Pyenson B, Fitch K, Spence C, Iwasaki K. Comparing hospice and nonhospice patient survival among patients who die within a three-year window. J Pain Symptom Manage 2007; 33 (3) 238-246
• 60 Prince-Paul M, Burant CJ, Saltzman JN, Teston LJ, Matthews CR. The effects of integrating an advanced practice palliative care nurse in a community oncology center: a pilot study. J Support Oncol 2010; 8 (1) 21-27
• 61 Movsas B, Moughan J, Sarna L , et al. Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. J Clin Oncol 2009; 27 (34) 5816-5822
• 62 Pirl WF, Temel JS, Billings A , et al. Depression after diagnosis of advanced non-small cell lung cancer and survival: a pilot study. Psychosomatics 2008; 49 (3) 218-224
• 63 Pirl WF, Greer JA, Traeger L , et al. Depression and survival in metastatic non-small-cell lung cancer: effects of early palliative care. J Clin Oncol 2012; 30 (12) 1310-1315
• 64 Irwin KE, Greer JA, Khatib J, Temel JS, Pirl WF. Early palliative care and metastatic non-small cell lung cancer: potential mechanisms of prolonged survival. Chron Respir Dis 2013; 10 (1) 35-47
• 65 Higginson IJ, Finlay IG, Goodwin DM , et al. Is there evidence that palliative care teams alter end-of-life experiences of patients and their caregivers?. J Pain Symptom Manage 2003; 25 (2) 150-168
• 66 Higginson IJ, Evans CJ. What is the evidence that palliative care teams improve outcomes for cancer patients and their families?. Cancer J 2010; 16 (5) 423-435
• 67 World Health Organization. Cancer pain relief: with a guide to opioid availability - 2nd ed. Geneva: 1996
• 68 Shamji FM, Deslauriers J. Surgeon's view: is palliative resection of lung cancer ever justified?. Thorac Surg Clin 2013; 23 (3) 383-399
• 69 Fujita T, Tanabe M, Moritani K, Matsunaga N, Matsumoto T. Immediate and late outcomes of bronchial and systemic artery embolization for palliative treatment of patients with nonsmall-cell lung cancer having hemoptysis. Am J Hosp Palliat Care 2014; 31 (6) 602-607
• 70 Rueda JR, Solà I, Pascual A, Subirana Casacuberta M. Non-invasive interventions for improving well-being and quality of life in patients with lung cancer. Cochrane Database Syst Rev 2011; (9) CD004282
• 71 Wall LM. Changes in hope and power in lung cancer patients who exercise. Nurs Sci Q 2000; 13 (3) 234-242
• 72 Gustafson DH, DuBenske LL, Namkoong K , et al. An eHealth system supporting palliative care for patients with non-small cell lung cancer: a randomized trial. Cancer 2013; 119 (9) 1744-1751
• 73 Payne C, Larkin PJ, McIlfatrick S, Dunwoody L, Gracey JH. Exercise and nutrition interventions in advanced lung cancer: a systematic review. Curr Oncol 2013; 20 (4) e321-e337
• 74 Bade BC, Thomas DD, Scott JB, Silvestri GA. Increasing physical activity and exercise in lung cancer: reviewing safety, benefits, and application. J Thorac Oncol 2015; 10 (6) 861-871
• 75 Cohen SR, Boston P, Mount BM, Porterfield P. Changes in quality of life following admission to palliative care units. Palliat Med 2001; 15 (5) 363-371
• 76 El-Jawahri A, Greer JA, Temel JS. Does palliative care improve outcomes for patients with incurable illness? A review of the evidence. J Support Oncol 2011; 9 (3) 87-94
• 77 Bakitas M, Lyons KD, Hegel MT , et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the project ENABLE II randomized controlled trial. JAMA 2009; 302 (7) 741-749
• 78 Rabow MW, Petersen J, Schanche K, Dibble SL, McPhee SJ. The comprehensive care team: a description of a controlled trial of care at the beginning of the end of life. J Palliat Med 2003; 6 (3) 489-499
• 79 Rabow MW, Schanche K, Petersen J, Dibble SL, McPhee SJ. Patient perceptions of an outpatient palliative care intervention: “It had been on my mind before, but I did not know how to start talking about death...”. J Pain Symptom Manage 2003; 26 (5) 1010-1015
• 80 Rabow MW, Dibble SL, Pantilat SZ, McPhee SJ. The comprehensive care team: a controlled trial of outpatient palliative medicine consultation. Arch Intern Med 2004; 164 (1) 83-91
• 81 Ferrell B, Sun V, Hurria A , et al. Interdisciplinary palliative care for patients with lung cancer. J Pain Symptom Manage 2015; 50 (6) 758-767
• 82 Elting LS, Avritscher EB, Cooksley CD, Cardenas-Turanzas M, Garden AS, Chambers MS. Psychosocial and economic impact of cancer. Dent Clin North Am 2008; 52 (1) 231-252 , x
• 83 Carmack Taylor CL, Badr H, Lee JH , et al. Lung cancer patients and their spouses: psychological and relationship functioning within 1 month of treatment initiation. Ann Behav Med 2008; 36 (2) 129-140
• 84 Braun M, Mikulincer M, Rydall A, Walsh A, Rodin G. Hidden morbidity in cancer: spouse caregivers. J Clin Oncol 2007; 25 (30) 4829-4834
• 85 Covinsky KE, Goldman L, Cook EF , et al; SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. The impact of serious illness on patients' families. JAMA 1994; 272 (23) 1839-1844
• 86 Wendler D, Rid A. Systematic review: the effect on surrogates of making treatment decisions for others. Ann Intern Med 2011; 154 (5) 336-346
• 87 Abbott KH, Sago JG, Breen CM, Abernethy AP, Tulsky JA. Families looking back: one year after discussion of withdrawal or withholding of life-sustaining support. Crit Care Med 2001; 29 (1) 197-201
• 88 Wright AA, Keating NL, Balboni TA, Matulonis UA, Block SD, Prigerson HG. Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers' mental health. J Clin Oncol 2010; 28 (29) 4457-4464
• 89 Meyers FJ, Carducci M, Loscalzo MJ, Linder J, Greasby T, Beckett LA. Effects of a problem-solving intervention (COPE) on quality of life for patients with advanced cancer on clinical trials and their caregivers: simultaneous care educational intervention (SCEI): linking palliation and clinical trials. J Palliat Med 2011; 14 (4) 465-473
• 90 Teno JM, Clarridge BR, Casey V , et al. Family perspectives on end-of-life care at the last place of care. JAMA 2004; 291 (1) 88-93
• 91 Sun V, Grant M, Koczywas M , et al. Effectiveness of an interdisciplinary palliative care intervention for family caregivers in lung cancer. Cancer 2015; 121 (20) 3737-3745
• 92 Bradley EH, Prigerson H, Carlson MD, Cherlin E, Johnson-Hurzeler R, Kasl SV. Depression among surviving caregivers: does length of hospice enrollment matter?. Am J Psychiatry 2004; 161 (12) 2257-2262
• 93 Kris AE, Cherlin EJ, Prigerson H , et al. Length of hospice enrollment and subsequent depression in family caregivers: 13-month follow-up study. Am J Geriatr Psychiatry 2006; 14 (3) 264-269
• 94 Higginson I, Priest P. Predictors of family anxiety in the weeks before bereavement. Soc Sci Med 1996; 43 (11) 1621-1625
• 95 Teno JM, Shu JE, Casarett D, Spence C, Rhodes R, Connor S. Timing of referral to hospice and quality of care: length of stay and bereaved family members' perceptions of the timing of hospice referral. J Pain Symptom Manage 2007; 34 (2) 120-125
• 96 Wennberg JE, Fisher ES, Stukel TA, Skinner JS, Sharp SM, Bronner KK. Use of hospitals, physician visits, and hospice care during last six months of life among cohorts loyal to highly respected hospitals in the United States. BMJ 2004; 328 (7440) 607
• 97 Raftery JP, Addington-Hall JM, MacDonald LD , et al. A randomized controlled trial of the cost-effectiveness of a district co-ordinating service for terminally ill cancer patients. Palliat Med 1996; 10 (2) 151-161
• 98 Penrod JD, Deb P, Dellenbaugh C , et al. Hospital-based palliative care consultation: effects on hospital cost. J Palliat Med 2010; 13 (8) 973-979
• 99 Zimmermann C, Riechelmann R, Krzyzanowska M, Rodin G, Tannock I. Effectiveness of specialized palliative care: a systematic review. JAMA 2008; 299 (14) 1698-1709
• 100 Masters GA, Temin S, Azzoli CG , et al; American Society of Clinical Oncology Clinical Practice. Systemic therapy for stage IV non-small-cell lung cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 2015; 33 (30) 3488-3515
• 101 Helsing M, Bergman B, Thaning L, Hero U ; Joint Lung Cancer Study Group. Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial. Eur J Cancer 1998; 34 (7) 1036-1044
• 102 Harrison LD, Zhang-Salomons J, Mates M, Booth CM, King WD, Mackillop WJ. Comparing effectiveness with efficacy: outcomes of palliative chemotherapy for non-small-cell lung cancer in routine practice. Curr Oncol 2015; 22 (3) 184-191
• 103 Brown J, Thorpe H, Napp V , et al. Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer. J Clin Oncol 2005; 23 (30) 7417-7427
• 104 Avelino CU, Cardoso RM, Aguiar SS, Silva MJ. Assessment of quality of life in patients with advanced non-small cell lung carcinoma treated with a combination of carboplatin and paclitaxel. J Bras Pneumol 2015; 41 (2) 133-142
• 105 Hardy JR, Noble T, Smith IE. Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer. Br J Cancer 1989; 60 (5) 764-766
• 106 Shepherd FA, Dancey J, Ramlau R , et al. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol 2000; 18 (10) 2095-2103
• 107 Roszkowski K, Pluzanska A, Krzakowski M , et al. A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC). Lung Cancer 2000; 27 (3) 145-157
• 108 The Elderly Lung Cancer Vinorelbine Italian Study Group. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 1999; 91 (1) 66-72
• 109 Anderson H, Hopwood P, Stephens RJ , et al. Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer—a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-small cell lung cancer. Br J Cancer 2000; 83 (4) 447-453
• 110 Hanna N, Shepherd FA, Fossella FV , et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 2004; 22 (9) 1589-1597
• 111 Strøm HH, Bremnes RM, Sundstrøm SH, Helbekkmo N, Fløtten O, Aasebø U. Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group. Br J Cancer 2013; 109 (6) 1467-1475
• 112 Hui D, Elsayem A, De la Cruz M , et al. Availability and integration of palliative care at US cancer centers. JAMA 2010; 303 (11) 1054-1061
• 113 Yoong J, Park ER, Greer JA , et al. Early palliative care in advanced lung cancer: a qualitative study. JAMA Intern Med 2013; 173 (4) 283-290
• 114 Back AL, Park ER, Greer JA , et al. Clinician roles in early integrated palliative care for patients with advanced cancer: a qualitative study. J Palliat Med 2014; 17 (11) 1244-1248
• 115 Wentlandt K, Krzyzanowska MK, Swami N, Rodin GM, Le LW, Zimmermann C. Referral practices of oncologists to specialized palliative care. J Clin Oncol 2012; 30 (35) 4380-4386
• 116 Johnson CE, Girgis A, Paul CL, Currow DC. Cancer specialists' palliative care referral practices and perceptions: results of a national survey. Palliat Med 2008; 22 (1) 51-57
• 117 Lamont EB, Christakis NA. Physician factors in the timing of cancer patient referral to hospice palliative care. Cancer 2002; 94 (10) 2733-2737
• 118 Smith AK. Palliative care: an approach for all internists: comment on “Early palliative care in advanced lung cancer: a qualitative study”. JAMA Intern Med 2013; 173 (4) 291-292
• 119 Blum T, Schönfeld N. The lung cancer patient, the pneumologist and palliative care: a developing alliance. Eur Respir J 2015; 45 (1) 211-226
• 120 Shin J, Temel J. Integrating palliative care: when and how?. Curr Opin Pulm Med 2013; 19 (4) 344-349
• 121 Gelfman LP, Morrison RS. Research funding for palliative medicine. J Palliat Med 2008; 11 (1) 36-43
• 122 Gelfman LP, Du Q, Morrison RS. An update: NIH research funding for palliative medicine 2006 to 2010. J Palliat Med 2013; 16 (2) 125-129